These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9060881)

  • 1. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans.
    Wolf A; Zalpour C; Theilmeier G; Wang BY; Ma A; Anderson B; Tsao PS; Cooke JP
    J Am Coll Cardiol; 1997 Mar; 29(3):479-85. PubMed ID: 9060881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral L-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men.
    Adams MR; Forsyth CJ; Jessup W; Robinson J; Celermajer DS
    J Am Coll Cardiol; 1995 Oct; 26(4):1054-61. PubMed ID: 7560599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit.
    Wang BY; Singer AH; Tsao PS; Drexler H; Kosek J; Cooke JP
    J Am Coll Cardiol; 1994 Feb; 23(2):452-8. PubMed ID: 8294700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No effect of an L-arginine-enriched medical food (HeartBars) on endothelial function and platelet aggregation in subjects with hypercholesterolemia.
    Abdelhamed AI; Reis SE; Sane DC; Brosnihan KB; Preli RB; Herrington DM
    Am Heart J; 2003 Mar; 145(3):E15. PubMed ID: 12660684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nitric oxide-dependent inhibition of platelet aggregation in elderly patients with hypercholesterolemia].
    Ueda S; Katagiri M; Matsumoto Y; Nishimura T; Matsushita S; Mori M; Ozawa T; Orimo H
    Nihon Ronen Igakkai Zasshi; 2001 Mar; 38(2):177-84. PubMed ID: 11305031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesiveness of mononuclear cells in hypercholesterolemic humans is normalized by dietary L-arginine.
    Theilmeier G; Chan JR; Zalpour C; Anderson B; Wang BY; Wolf A; Tsao PS; Cooke JP
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3557-64. PubMed ID: 9437205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits.
    Tsao PS; Theilmeier G; Singer AH; Leung LL; Cooke JP
    Arterioscler Thromb; 1994 Oct; 14(10):1529-33. PubMed ID: 7918301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-arginine infusion decreases platelet aggregation through an intraplatelet nitric oxide release.
    Marietta M; Facchinetti F; Neri I; Piccinini F; Volpe A; Torelli G
    Thromb Res; 1997 Oct; 88(2):229-35. PubMed ID: 9361375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent.
    Anfossi G; Russo I; Massucco P; Mattiello L; Perna P; Tassone F; Trovati M
    Thromb Res; 1999 Jun; 94(5):307-16. PubMed ID: 10379819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients.
    Casino PR; Kilcoyne CM; Quyyumi AA; Hoeg JM; Panza JA
    J Am Coll Cardiol; 1994 Mar; 23(4):844-50. PubMed ID: 8106688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
    Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
    Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enhance nitric oxide activity.
    Maxwell AJ; Anderson B; Zapien MP; Cooke JP
    Cardiovasc Drugs Ther; 2000 Jun; 14(3):309-16. PubMed ID: 10935153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia.
    Maas R; Schwedhelm E; Kahl L; Li H; Benndorf R; Lüneburg N; Förstermann U; Böger RH
    Clin Chem; 2008 Feb; 54(2):292-300. PubMed ID: 18070819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
    Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
    Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.
    Wang BY; Candipan RC; Arjomandi M; Hsiun PT; Tsao PS; Cooke JP
    J Am Coll Cardiol; 1996 Nov; 28(6):1573-9. PubMed ID: 8917274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular effects of dietary L-arginine supplementation.
    Preli RB; Klein KP; Herrington DM
    Atherosclerosis; 2002 May; 162(1):1-15. PubMed ID: 11947892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous nitric oxide acts as a natural antithrombotic agent in vivo by inhibiting platelet aggregation in the pulmonary vasculature.
    Emerson M; Momi S; Paul W; Alberti PF; Page C; Gresele P
    Thromb Haemost; 1999 Jun; 81(6):961-6. PubMed ID: 10404776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term smoking impairs platelet-derived nitric oxide release.
    Ichiki K; Ikeda H; Haramaki N; Ueno T; Imaizumi T
    Circulation; 1996 Dec; 94(12):3109-14. PubMed ID: 8989117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased nitric oxide production in platelets from severe chronic renal failure patients.
    Siqueira MA; Brunini TM; Pereira NR; Martins MA; Moss MB; Santos SF; Lugon JR; Mendes-Ribeiro AC
    Can J Physiol Pharmacol; 2011 Feb; 89(2):97-102. PubMed ID: 21326340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.